biotechnology company optimizing protein expression using AI and proprietary intronization technology
ExpressionEdits has raised €12M across 1 funding round from 7 investors, most recently a Seed round in May 2024. Based in Cambridge, UK; active in Healthtech. Data as of 6 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-05-29 | Seed | €12M |
| Acequia Capital,Amino Collective,BlueYard Capital,Hawktail VC,Octopus Ventures,Redalpine+1 more |
| View deal → |
